Product Facts Supplement Facts Serving Size 1 Capsule Servings Per Container 60 Daily Value not established
The global market for GLP-1 receptor agonists is expected to grow at a rate of 1518% per year, and reach more than $20 billion by 2028
The differences become clearer when compared to other options on the market: Shed offers prescription GLP-1s with optional VIP coaching that adds one-on-one support and lifestyle guidance
Regional Analysis Latin America remains the dominant yerba mate market, rooted in strong cultural traditions and daily consumption habits
It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe baseline GLP-1 biology, giving you and your provider upstream context rather than a prescription recommendation
Metabolic Profile Beyond Fat Loss Tesamorelins visceral fat reduction translates into measurable metabolic improvements